Compass Pathways PLC

-$0.46 (-4.3%)
Closing price December 6, 2022
Wednesday's top analyst upgrades and downgrades included AppLovin, Arista Networks, Charles Schwab, First Solar, Global Payments, Halliburton, Monster Beverage, NXP Semiconductor, QuantumScape, Union...
Here is a look of a few of the biggest clinical trial and FDA updates in regards to psychedelics to watch for in 2022.
Here's a quick look at six publicly traded companies developing ways to use psychedelics to treat mental health issues.